At the virtual Annual General Meeting on May 20, 2021, the General Partner and the Supervisory Board proposed a dividend to shareholders of €1.34 per share. This equated to an increase of €0.14, or 11.7 % compared to the previous year, and an annual increase of around 9 % since 1997. With 292.9 M shares entitled to receive dividends (as at December 31, 2020), the total dividend payout thus amounted to €392 M; the payout ratio in relation to net income for 2020 came to around 34 %. Based on the dividend and the closing share price for 2020, the dividend yield on the shares was 2.0 % (2019: 1.8 %).
Fresenius Medical Care remains committed to its ambitious goal of closely aligning the development of its dividend with growth in earnings per share, while maintaining dividend continuity.